These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Neuropsychological significance of areas of high signal intensity on brain MRIs of children with neurofibromatosis. Moore BD, Slopis JM, Schomer D, Jackson EF, Levy BM. Neurology; 1996 Jun; 46(6):1660-8. PubMed ID: 8649566 [Abstract] [Full Text] [Related]
4. Functional Connectivity Changes and Executive and Social Problems in Neurofibromatosis Type I. Loitfelder M, Huijbregts SC, Veer IM, Swaab HS, Van Buchem MA, Schmidt R, Rombouts SA. Brain Connect; 2015 Jun; 5(5):312-20. PubMed ID: 25705926 [Abstract] [Full Text] [Related]
13. Assessment of executive function and attention in children with neurofibromatosis type 1: relationships between cognitive measures and real-world behavior. Payne JM, Hyman SL, Shores EA, North KN. Child Neuropsychol; 2011 Jun; 17(4):313-29. PubMed ID: 21347908 [Abstract] [Full Text] [Related]
14. Neurofibromatosis type 1: motor and cognitive function and T2-weighted MRI hyperintensities. Feldmann R, Denecke J, Grenzebach M, Schuierer G, Weglage J. Neurology; 2003 Dec 23; 61(12):1725-8. PubMed ID: 14694037 [Abstract] [Full Text] [Related]
16. Neuropsychological profile in adults with neurofibromatosis type 1 compared to a control group. Descheemaeker MJ, Plasschaert E, Frijns JP, Legius E. J Intellect Disabil Res; 2013 Sep 23; 57(9):874-86. PubMed ID: 23095048 [Abstract] [Full Text] [Related]
17. Parent and Teacher Perspectives on Emerging Executive Functioning in Preschoolers With Neurofibromatosis Type 1: Comparison to Unaffected Children and Lab-Based Measures. Casnar CL, Klein-Tasman BP. J Pediatr Psychol; 2017 Mar 01; 42(2):198-207. PubMed ID: 27189686 [Abstract] [Full Text] [Related]